|
A reduction
in GH is associated with increased risk of death and enhanced fat mass. There is some evidence that GH action may be
important for mitochondrial regulation in skeletal muscle. Mitochondria are sometimes described as
"cellular power plants" because they generate most of the cell's
supply of adenosine triphosphate (ATP), used as a source of chemical energy. In
addition to supplying cellular energy, mitochondria are involved in a range of
other processes, such as signaling, cellular differentiation, cell death, as
well as the control of the cell cycle and cell growth. Loss of mitochondria has been implicated in
several human diseases and may play a role in the aging process. Exercise is a
potent stimulus of GH release, and thus it is possible that GH action contributes
too many exercise induced mitochondrial adaptations, including increased mitochondrial
creation and fat utilization.
Researchers from the Rochester, MN Mayo Clinic School of Medicine
investigated the effects of GH on mitochondrial activity, protein synthesis,
and fat utilization in young adults. They infused GH (150 microg/h) for 14 h on
separate days, and muscle biopsies were obtained. They found a 14-h infusion of GH causing physiological elevation of GH
resulted in increased skeletal muscle mitochondrial oxidative capacity, as
shown by increased mitochondrial ATP production rate. Plasma fatty acid concentration was nearly
doubled during GH infusion compared with saline and was accompanied by a shift
in fuel metabolism toward greater reliance on fat. GH had no effect on muscle
protein synthesis. Interestingly, the lack of effect of GH on
muscle protein synthesis rate occurred despite an increased activation
(phosphorylation) of mTOR, a key energy sensing anabolic signal molecule. The age related decrease in GH which causes
reduced mitochondrial activity may be the reason why low GH levels are
associated with increased risk of dying.
Short KR, Moller N, Bigelow ML, Coenen-Schimke J, Nair
KS. Enhancement of muscle mitochondrial function by
growth hormone. J Clin Endocrinol Metab. 2008
Feb;93(2):597-604.
|